KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Debt to Equity (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Debt to Equity for 16 consecutive years, with $0.72 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Debt to Equity fell 7.33% year-over-year to $0.72, compared with a TTM value of $0.72 through Sep 2024, down 7.33%, and an annual FY2023 reading of $0.75, down 4.59% over the prior year.
  • Debt to Equity was $0.72 for Q3 2024 at Thermo Fisher Scientific, down from $0.75 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.85 in Q4 2021 and bottomed at $0.51 in Q3 2021.
  • Average Debt to Equity over 5 years is $0.71, with a median of $0.72 recorded in 2024.
  • The sharpest move saw Debt to Equity dropped 28.67% in 2021, then soared 52.49% in 2022.
  • Year by year, Debt to Equity stood at $0.63 in 2020, then skyrocketed by 35.54% to $0.85 in 2021, then fell by 8.23% to $0.78 in 2022, then dropped by 4.59% to $0.75 in 2023, then dropped by 3.51% to $0.72 in 2024.
  • Business Quant data shows Debt to Equity for TMO at $0.72 in Q3 2024, $0.75 in Q2 2024, and $0.78 in Q1 2024.